Brief: Newron Pharmaceuticals FY Net Loss Widens To EUR 20.2 Million
05/03/2020 06:08
March 5 (Reuters) - Newron Pharmaceuticals SpA NWRN.S :
* NEWRON PHARMACEUTICALS SPA - IN 2019, NEWRON REPORTED A
NET LOSS
OF EUR 20.2 MILLION, COMPARED TO EUR 15.0 MILLION IN 2018.
Source text for Eikon: urn:newsml:reuters.com:*:nTENw4fzca
Further company coverage: NWRN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Newron Pharmaceuticals SpA
See all newsUS FDA flags four deaths in Newron's schizophrenia drug studies (updated)
US FDA cites 4 deaths in Newron's schizophrenia drug trial hold
Brief: Newron Says Topline Data From ENIGMA-TRS 1 Expected In Q1 2027
Brief: Newron Provides Update Following Type A Meeting With The FDA
Brief: Newron Reports Pause Of Enrollment Of New Study Participants In US Centers Of ENIGMA-TRS 2 Study